Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
PaperCitations, authors & open-access status
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,691 citations, 2018 year and bronze oa status.
4,691
Citations
2018
Year
bronze
OA Status